XHR3XGAReplacement of Back Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10

New Technology›Skin, Subcutaneous Tissue, Fascia and Breast›Replacement
  • Billable / Specific Code
ICD-10-PCS XHR3XGA
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

XHR3XGA is a billable ICD-10-PCS procedure code for Replacement of Back Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Replacement involves putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part.

Code Identity

ICD-10-PCS Code
XHR3XGA
Billable Status
Yes — Valid for Submission
Code Describes
Replacement of Back Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
Parent Code
XHR New Technology, Skin, Subcutaneous Tissue, Fascia and Breast, Replacement
Short Description
Replace Back Skin w pz-cel, Extern, New Tech 10

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemHSkin, Subcutaneous Tissue, Fascia and Breast
3OperationRReplacement
4BodyPart3Skin, Back
5ApproachXExternal
6Device/Substance/TechnologyGPrademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy
7QualifierANew Technology Group 10

Code History

Replaces previously assigned code(s):
  • 0HR6X73 — Replace Back Skin w Autol Sub, Full Thick, Extern

Similar Procedure Codes

Questions About XHR3XGA

Is XHR3XGA a billable code?

Yes. XHR3XGA is a complete seven-character ICD-10-PCS code, specific enough to report Replacement of Back Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XHR3XGA mean?

XHR3XGA breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character H is the Body System (Skin, Subcutaneous Tissue, Fascia and Breast); the 3rd character R is the Operation (Replacement); the 4th character 3 is the BodyPart (Skin, Back); the 5th character X is the Approach (External); the 6th character G is the Device/Substance/Technology (Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy); the 7th character A is the Qualifier (New Technology Group 10).